Quantcast
Channel: Articles tagged with Pharmacy Benefit Manager from Medical Marketing and Media
Browsing latest articles
Browse All 26 View Live

Five things for pharma marketers to know: Tuesday, March 21, 2017

Eli Lilly claims it only realizes small percentage of list price increases; PBMs become latest target in pricing backlash; AHCA revised

View Article



Five things for pharma marketers to know: Tuesday, April 4, 2017

Mylan allegedly increased EpiPen list price to appease PBMs; 20% of patients misdiagnosed by primary-care doctor: study; Mallinckrodt settles DEA probe

View Article

Five things for pharma marketers to know: Tuesday, April 25, 2017

Sanofi sues Mylan over anticompetitive practices; Anthem to drop Express Scripts; GSK chief digital officer says advertisers should focus on fewer publishers

View Article

Five things for pharma marketers to know: Wednesday, August 9, 2017

The FDA on pace for record generic drug approvals; CVS Health CEO doubts Amazon's entrance to pharmacy market; Sanofi to develop cancer immunotherapy

View Article

Five things for pharma marketers to know: Friday, September 22, 2017

Express Scripts' Miller says new models needed to pay for CAR-T; FDA warns about Intercept drug deaths; CVS puts limits on opioid scripts

View Article


Five things for pharma marketers to know: Friday, October 27, 2017

CVS Health reportedly in talks to acquire Aetna; Amazon acquires wholesale pharmacy licenses; Merck says June cyberattack disrupted global operations

View Article

Armed with predictive analytics, PBMs push adherence as a stand-in for outcomes

Pharmacy benefit managers are increasingly measuring a patient's outcome in the context of adherence.

View Article

Five things for pharma marketers to know: Monday, December 4, 2017

CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate

View Article


Five things for pharma marketers to know: Monday, December 18, 2017

CVS/Aetna deal will affect healthcare benefits; lawmakers pressure DEA to curb painkiller supply; Allergan and Richter's Vraylar sees positive results for bipolar depression

View Article


MM&M's 5 most-read technology stories of 2017

Digital innovation in Japan, health-tech trends, and social media top the list.

View Article
Browsing latest articles
Browse All 26 View Live




Latest Images